Baldero, Melisa E.

HRN: 23-48-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
CEFUROXIME 1.5GM (VIAL)
11/26/2023
11/28/2023
IV
1.5grams
Q8hrs X 3 Doses
Thickly MSAF; T/C IUFD
Waiting Final Action 
11/29/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/29/2023
12/06/2023
IV
500mg
Q8
G1P0 40 5/7 Weeks AOG; IUFD
Waiting Final Action 
12/11/2023
CEFTRIAXONE 1G (VIAL)
12/11/2023
12/11/2023
IV
1.5
OD
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: